-+ 0.00%
-+ 0.00%
-+ 0.00%

SRX Global Acquires Stake In Vistagen Therapeutics; Deal Terms Were Undisclosed

Benzinga·08/04/2026 09:20:47
Listen to the news

The Company views Vistagen shares as undervalued and welcomes constructive engagement with its leadership team and Board of Directors to discuss ideas on how to unlock shareholder value.